HB/APAP
HB/APAP is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty
Clinical Trials (6)
Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty
A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6